Comparison of CGM data between iPro2 and Libre Pro in diabetes mellitus patients undergoing hemodialysis

Comparison of CGM data between iPro2 and Libre Pro in diabetes mellitus patients undergoing hemodialysis - Comparison of CGM data between iPro2 and Libre Pro

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032979

Enrollment

Registered

2018-06-13

Start date

2018-06-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus patients on hemodialysis

Interventions

CGM by iPro2 and Libre Pro

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetes mellitus patients undergoing hemodialysis whose diabetes treatment regimens has not been changed within three months

Exclusion criteria

Exclusion criteria: type 1 diabetes, chronic liver disease, thyroid dysfunction, gastrointestinal bleeding

Design outcomes

Primary

Measure	Time frame
Mean, maximum, minimum, and SD of glucose levels. The correlation between HbA1c or GA and mean glucose levels obtained by CGM	—

Countries

Japan

Contacts

Public ContactTakahiro Yajima

Matsunami general hospital Department of Nephrology

yajima5639@gmail.com058-388-0111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026